ID   CARD8_HUMAN             Reviewed;         431 AA.
AC   Q9Y2G2; B5KVR6; B7Z496; B7Z4A2; E9PEM7; G3XAM9; Q6PGP8; Q96P82;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   07-APR-2021, entry version 185.
DE   RecName: Full=Caspase recruitment domain-containing protein 8;
DE   AltName: Full=Apoptotic protein NDPP1;
DE   AltName: Full=CARD-inhibitor of NF-kappa-B-activating ligand;
DE            Short=CARDINAL;
DE   AltName: Full=DACAR;
DE   AltName: Full=Tumor up-regulated CARD-containing antagonist of CASP9;
DE            Short=TUCAN;
GN   Name=CARD8; Synonyms=KIAA0955, NDPP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH CARD16 AND
RP   CARD18.
RX   PubMed=11821383; DOI=10.1074/jbc.m107811200;
RA   Razmara M., Srinivasula S.M., Wang L., Poyet J.-L., Geddes B.J.,
RA   DiStefano P.S., Bertin J., Alnemri E.S.;
RT   "CARD-8 protein, a new CARD family member that regulates caspase-1
RT   activation and apoptosis.";
RL   J. Biol. Chem. 277:13952-13958(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11956601;
RA   Zhang H., Fu W.;
RT   "NDPP1 is a novel CARD domain containing protein which can inhibit
RT   apoptosis and suppress NF-kappaB activation.";
RL   Int. J. Oncol. 20:1035-1040(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Guiet C., Vito P.;
RT   "DACAR, a novel CARD-containing protein.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11551959; DOI=10.1074/jbc.m107373200;
RA   Bouchier-Hayes L., Conroy H., Egan H., Adrain C., Creagh E.M.,
RA   MacFarlane M., Martin S.J.;
RT   "CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of
RT   multiple NF-kappa B activation pathways.";
RL   J. Biol. Chem. 276:44069-44077(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND ALTERNATIVE SPLICING.
RX   PubMed=18212821; DOI=10.1038/sj.ejhg.5201996;
RA   Bagnall R.D., Roberts R.G., Mirza M.M., Torigoe T., Prescott N.J.,
RA   Mathew C.G.;
RT   "Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation.";
RL   Eur. J. Hum. Genet. 16:619-625(2008).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RA   Guo J.H., Yu L.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND VARIANTS
RP   VAL-68 AND ALA-99.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 178-198, AUTOCATALYTIC CLEAVAGE, AND MUTAGENESIS OF
RP   GLU-135; GLU-137; HIS-147; HIS-164; GLU-173; HIS-174; SER-189; PHE-190;
RP   SER-191 AND HIS-227.
RX   PubMed=22087307; DOI=10.1371/journal.pone.0027396;
RA   D'Osualdo A., Weichenberger C.X., Wagner R.N., Godzik A., Wooley J.,
RA   Reed J.C.;
RT   "CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like
RT   domain.";
RL   PLoS ONE 6:E27396-E27396(2011).
RN   [13]
RP   CHARACTERIZATION.
RX   PubMed=11408476; DOI=10.1074/jbc.m100433200;
RA   Pathan N., Marusawa H., Krajewska M., Matsuzawa S., Kim H., Okada K.,
RA   Torii S., Kitada S., Krajewski S., Welsh K., Pio F., Godzik A., Reed J.C.;
RT   "TUCAN, an antiapoptotic caspase-associated recruitment domain family
RT   protein overexpressed in cancer.";
RL   J. Biol. Chem. 276:32220-32229(2001).
RN   [14]
RP   CHARACTERIZATION, AND MUTAGENESIS OF LEU-366.
RX   PubMed=12067710; DOI=10.1016/s0014-5793(02)02869-7;
RA   Stilo R., Leonardi A., Formisano L., Di Jeso B., Vito P., Liguoro D.;
RT   "TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of
RT   NF-kappaB activation.";
RL   FEBS Lett. 521:165-169(2002).
RN   [15]
RP   INTERACTION WITH NALP2, AND SUBCELLULAR LOCATION.
RX   PubMed=15030775; DOI=10.1016/s1074-7613(04)00046-9;
RA   Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N.,
RA   Tschopp J.;
RT   "NALP3 forms an IL-1beta-processing inflammasome with increased activity in
RT   Muckle-Wells autoinflammatory disorder.";
RL   Immunity 20:319-325(2004).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.46 ANGSTROMS) OF 345-431.
RX   PubMed=23695559; DOI=10.1107/s1744309113010075;
RA   Jin T., Huang M., Smith P., Jiang J., Xiao T.S.;
RT   "The structure of the CARD8 caspase-recruitment domain suggests its
RT   association with the FIIND domain and procaspases through adjacent
RT   surfaces.";
RL   Acta Crystallogr. F 69:482-487(2013).
CC   -!- FUNCTION: Inhibits NF-kappa-B activation. May participate in a
CC       regulatory mechanism that coordinates cellular responses controlled by
CC       NF-kappa-B transcription factor. May be a component of the
CC       inflammasome, a protein complex which also includes PYCARD, NALP2 and
CC       CASP1 and whose function would be the activation of proinflammatory
CC       caspases.
CC   -!- SUBUNIT: May form homodimers. Interacts with NEMO and DRAL. Binds to
CC       caspase-1, CARD16/pseudo-ICE and CARD18/ICEBERG. Interacts with FNBP3
CC       (By similarity). Interacts with NALP2 NACHT domain. {ECO:0000250,
CC       ECO:0000269|PubMed:11821383, ECO:0000269|PubMed:15030775}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15030775}. Nucleus
CC       {ECO:0000269|PubMed:15030775}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q9Y2G2-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q9Y2G2-2; Sequence=VSP_000782, VSP_000783;
CC       Name=3;
CC         IsoId=Q9Y2G2-3; Sequence=VSP_012770, VSP_012771, VSP_000782,
CC                                  VSP_000783;
CC       Name=4;
CC         IsoId=Q9Y2G2-4; Sequence=VSP_045253, VSP_012771;
CC       Name=5; Synonyms=T60;
CC         IsoId=Q9Y2G2-5; Sequence=VSP_012770, VSP_012771;
CC   -!- TISSUE SPECIFICITY: High expression in lung, ovary, testis and
CC       placenta. Lower expression in heart, kidney and liver. Also expressed
CC       in spleen, lymph node and bone marrow.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76799.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CARD8ID913ch19q13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB023172; BAA76799.2; ALT_INIT; mRNA.
DR   EMBL; AF322184; AAG50014.1; -; mRNA.
DR   EMBL; AF331519; AAK01126.1; -; mRNA.
DR   EMBL; AY026322; AAK08982.1; -; mRNA.
DR   EMBL; AF405558; AAL02427.1; -; mRNA.
DR   EMBL; EU118120; ABW96891.1; -; mRNA.
DR   EMBL; AF511652; AAM46959.1; -; mRNA.
DR   EMBL; AK297045; BAH12482.1; -; mRNA.
DR   EMBL; AK297069; BAH12488.1; -; mRNA.
DR   EMBL; AC008392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52321.1; -; Genomic_DNA.
DR   EMBL; CH471177; EAW52323.1; -; Genomic_DNA.
DR   EMBL; BC056891; AAH56891.1; -; mRNA.
DR   CCDS; CCDS12712.2; -. [Q9Y2G2-4]
DR   CCDS; CCDS54288.1; -. [Q9Y2G2-3]
DR   CCDS; CCDS54289.1; -. [Q9Y2G2-5]
DR   RefSeq; NP_001171829.1; NM_001184900.1. [Q9Y2G2-5]
DR   RefSeq; NP_001171830.1; NM_001184901.1. [Q9Y2G2-4]
DR   RefSeq; NP_001171831.1; NM_001184902.1. [Q9Y2G2-3]
DR   RefSeq; NP_001171832.1; NM_001184903.1. [Q9Y2G2-3]
DR   RefSeq; NP_055774.2; NM_014959.3. [Q9Y2G2-4]
DR   RefSeq; XP_006723154.1; XM_006723091.3. [Q9Y2G2-5]
DR   RefSeq; XP_006723155.1; XM_006723092.3. [Q9Y2G2-5]
DR   RefSeq; XP_006723156.1; XM_006723093.3. [Q9Y2G2-5]
DR   RefSeq; XP_006723158.1; XM_006723095.3.
DR   RefSeq; XP_006723159.1; XM_006723096.3. [Q9Y2G2-4]
DR   RefSeq; XP_006723160.1; XM_006723097.3. [Q9Y2G2-4]
DR   RefSeq; XP_006723167.1; XM_006723104.3. [Q9Y2G2-1]
DR   RefSeq; XP_006723169.1; XM_006723106.3. [Q9Y2G2-3]
DR   RefSeq; XP_006723172.1; XM_006723109.3. [Q9Y2G2-2]
DR   RefSeq; XP_011524943.1; XM_011526641.2. [Q9Y2G2-5]
DR   RefSeq; XP_011524944.1; XM_011526642.2.
DR   RefSeq; XP_011524945.1; XM_011526643.2. [Q9Y2G2-5]
DR   RefSeq; XP_011524946.1; XM_011526644.2. [Q9Y2G2-5]
DR   RefSeq; XP_011524952.1; XM_011526650.2. [Q9Y2G2-3]
DR   RefSeq; XP_016881972.1; XM_017026483.1. [Q9Y2G2-4]
DR   RefSeq; XP_016881979.1; XM_017026490.1.
DR   RefSeq; XP_016881987.1; XM_017026498.1. [Q9Y2G2-2]
DR   PDB; 4IKM; X-ray; 2.46 A; A=345-431.
DR   PDB; 6K9F; EM; 3.70 A; A/B/C/D/E/F/G/H/I/J/K/L=345-431.
DR   PDB; 6XKJ; EM; 3.54 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=345-431.
DR   PDBsum; 4IKM; -.
DR   PDBsum; 6K9F; -.
DR   PDBsum; 6XKJ; -.
DR   SMR; Q9Y2G2; -.
DR   BioGRID; 116564; 47.
DR   CORUM; Q9Y2G2; -.
DR   IntAct; Q9Y2G2; 37.
DR   MINT; Q9Y2G2; -.
DR   STRING; 9606.ENSP00000375767; -.
DR   MEROPS; S79.001; -.
DR   iPTMnet; Q9Y2G2; -.
DR   PhosphoSitePlus; Q9Y2G2; -.
DR   BioMuta; CARD8; -.
DR   DMDM; 14424229; -.
DR   EPD; Q9Y2G2; -.
DR   MassIVE; Q9Y2G2; -.
DR   PaxDb; Q9Y2G2; -.
DR   PeptideAtlas; Q9Y2G2; -.
DR   PRIDE; Q9Y2G2; -.
DR   ProteomicsDB; 19923; -.
DR   ProteomicsDB; 33792; -.
DR   ProteomicsDB; 85761; -. [Q9Y2G2-1]
DR   ProteomicsDB; 85762; -. [Q9Y2G2-2]
DR   ProteomicsDB; 85763; -. [Q9Y2G2-3]
DR   Antibodypedia; 18287; 306 antibodies.
DR   Ensembl; ENST00000391898; ENSP00000375767; ENSG00000105483. [Q9Y2G2-5]
DR   Ensembl; ENST00000447740; ENSP00000391248; ENSG00000105483. [Q9Y2G2-4]
DR   Ensembl; ENST00000519940; ENSP00000428883; ENSG00000105483. [Q9Y2G2-5]
DR   Ensembl; ENST00000520015; ENSP00000430747; ENSG00000105483. [Q9Y2G2-3]
DR   Ensembl; ENST00000520153; ENSP00000428736; ENSG00000105483. [Q9Y2G2-4]
DR   Ensembl; ENST00000520753; ENSP00000429839; ENSG00000105483. [Q9Y2G2-3]
DR   Ensembl; ENST00000521613; ENSP00000427858; ENSG00000105483. [Q9Y2G2-4]
DR   Ensembl; ENST00000651546; ENSP00000499211; ENSG00000105483. [Q9Y2G2-5]
DR   GeneID; 22900; -.
DR   KEGG; hsa:22900; -.
DR   UCSC; uc002pih.5; human. [Q9Y2G2-1]
DR   CTD; 22900; -.
DR   DisGeNET; 22900; -.
DR   GeneCards; CARD8; -.
DR   HGNC; HGNC:17057; CARD8.
DR   HPA; ENSG00000105483; Low tissue specificity.
DR   MIM; 609051; gene.
DR   neXtProt; NX_Q9Y2G2; -.
DR   OpenTargets; ENSG00000105483; -.
DR   PharmGKB; PA134916154; -.
DR   VEuPathDB; HostDB:ENSG00000105483.16; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   GeneTree; ENSGT00830000128447; -.
DR   HOGENOM; CLU_037186_1_0_1; -.
DR   InParanoid; Q9Y2G2; -.
DR   OMA; MEPLNFG; -.
DR   OrthoDB; 559093at2759; -.
DR   PhylomeDB; Q9Y2G2; -.
DR   TreeFam; TF352798; -.
DR   PathwayCommons; Q9Y2G2; -.
DR   Reactome; R-HSA-111458; Formation of apoptosome.
DR   Reactome; R-HSA-9627069; Regulation of the apoptosome activity.
DR   SIGNOR; Q9Y2G2; -.
DR   BioGRID-ORCS; 22900; 10 hits in 999 CRISPR screens.
DR   ChiTaRS; CARD8; human.
DR   GeneWiki; CARD8; -.
DR   GenomeRNAi; 22900; -.
DR   Pharos; Q9Y2G2; Tbio.
DR   PRO; PR:Q9Y2G2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9Y2G2; protein.
DR   Bgee; ENSG00000105483; Expressed in spleen and 217 other tissues.
DR   ExpressionAtlas; Q9Y2G2; baseline and differential.
DR   Genevisible; Q9Y2G2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0061702; C:inflammasome complex; IBA:GO_Central.
DR   GO; GO:0072559; C:NLRP3 inflammasome complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0050700; F:CARD domain binding; IPI:UniProtKB.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:HGNC-UCL.
DR   GO; GO:0032089; F:NACHT domain binding; IPI:HGNC-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC-UCL.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IBA:GO_Central.
DR   GO; GO:0097340; P:inhibition of cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:HGNC-UCL.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; IDA:UniProtKB.
DR   GO; GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; IDA:HGNC-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   GO; GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IBA:GO_Central.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR025307; FIIND_dom.
DR   Pfam; PF00619; CARD; 1.
DR   Pfam; PF13553; FIIND; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
DR   PROSITE; PS51830; FIIND; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Cytoplasm;
KW   Direct protein sequencing; Nucleus; Reference proteome.
FT   CHAIN           1..431
FT                   /note="Caspase recruitment domain-containing protein 8"
FT                   /id="PRO_0000144080"
FT   DOMAIN          56..340
FT                   /note="FIIND"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01174"
FT   DOMAIN          340..430
FT                   /note="CARD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   SITE            190..191
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01174,
FT                   ECO:0000269|PubMed:22087307"
FT   VAR_SEQ         1..25
FT                   /note="MMRQRQSHYCSVLFLSVNYLGGTFP -> MEKKECPEKSSSSEEELPRRDSG
FT                   SSRNIDASKLIRLQGSRKLLVDNSIRELQYTKTGIFFQAEACVTNDTVYRELPCVSETL
FT                   CDISHFFQEDDETEAEPLLFRAVPECQLSGGDIPSVSEEQESSEGQDS (in
FT                   isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:18212821"
FT                   /id="VSP_012770"
FT   VAR_SEQ         1..25
FT                   /note="MMRQRQSHYCSVLFLSVNYLGGTFP -> MEKKECPEKSSSSEEELPRRVYR
FT                   ELPCVSETLCDISHFFQEDDETEAEPLLFRAVPECQLSGGDIPSVSEEQESSEGQDS
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045253"
FT   VAR_SEQ         152
FT                   /note="Q -> QA (in isoform 3, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:18212821"
FT                   /id="VSP_012771"
FT   VAR_SEQ         282..286
FT                   /note="ELKLS -> WISSL (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.7"
FT                   /id="VSP_000782"
FT   VAR_SEQ         287..431
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.7"
FT                   /id="VSP_000783"
FT   VARIANT         68
FT                   /note="I -> V (in dbSNP:rs11881179)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_048606"
FT   VARIANT         99
FT                   /note="E -> A (in dbSNP:rs59878320)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_061079"
FT   MUTAGEN         135
FT                   /note="E->A: No effect on autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         137
FT                   /note="E->A: No effect on autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         147
FT                   /note="H->A: Severe loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         164
FT                   /note="H->A: Severe loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         173
FT                   /note="E->A: Partial loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         174
FT                   /note="H->A: No effect on autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         189
FT                   /note="S->A: Partial loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         189
FT                   /note="S->Q: No effect on autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         190
FT                   /note="F->H: Severe loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         191
FT                   /note="S->A: Complete loss of autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         227
FT                   /note="H->A: No effect on autocatalytic cleavage."
FT                   /evidence="ECO:0000269|PubMed:22087307"
FT   MUTAGEN         366
FT                   /note="L->R: Inhibits homodimer formation."
FT                   /evidence="ECO:0000269|PubMed:12067710"
FT   CONFLICT        60
FT                   /note="E -> G (in Ref. 5; AAL02427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="F -> S (in Ref. 11; AAH56891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219
FT                   /note="P -> R (in Ref. 8; BAH12488)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        326
FT                   /note="V -> M (in Ref. 5; AAL02427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        417
FT                   /note="E -> G (in Ref. 6; ABW96891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        422
FT                   /note="L -> P (in Ref. 5; AAL02427)"
FT                   /evidence="ECO:0000305"
FT   HELIX           345..350
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           352..358
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           363..371
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           377..385
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   STRAND          386..388
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           389..401
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           405..418
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           420..424
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   HELIX           427..431
FT                   /evidence="ECO:0007744|PDB:4IKM"
FT   CONFLICT        Q9Y2G2-5:84
FT                   /note="D -> G (in Ref. 6; ABW96891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        Q9Y2G2-5:107
FT                   /note="E -> D (in Ref. 6; ABW96891)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   431 AA;  48933 MW;  CB54D130807732E6 CRC64;
     MMRQRQSHYC SVLFLSVNYL GGTFPGDICS EENQIVSSYA SKVCFEIEED YKNRQFLGPE
     GNVDVELIDK STNRYSVWFP TAGWYLWSAT GLGFLVRDEV TVTIAFGSWS QHLALDLQHH
     EQWLVGGPLF DVTAEPEEAV AEIHLPHFIS LQGEVDVSWF LVAHFKNEGM VLEHPARVEP
     FYAVLESPSF SLMGILLRIA SGTRLSIPIT SNTLIYYHPH PEDIKFHLYL VPSDALLTKA
     IDDEEDRFHG VRLQTSPPME PLNFGSSYIV SNSANLKVMP KELKLSYRSP GEIQHFSKFY
     AGQMKEPIQL EITEKRHGTL VWDTEVKPVD LQLVAASAPP PFSGAAFVKE NHRQLQARMG
     DLKGVLDDLQ DNEVLTENEK ELVEQEKTRQ SKNEALLSMV EKKGDLALDV LFRSISERDP
     YLVSYLRQQN L
//
